This procurement opportunity is part of the project "Improving the Quality and Accessibility of Oncology Diagnostics and Treatment at the University Clinical Center," funded by the National Recovery and Resilience Plan. The project aims to enhance the efficiency, accessibility, and quality of the he
Contract awarded. Originally published 11 months ago.
This contract involves the supply of laboratory reagents and materials for IHC (Immunohistochemistry) and ISH (In Situ Hybridization) staining, along with the leasing of necessary equipment for the Clinical Pathology Department at the University Clinical Center. The required specifications, estimate
This procurement opportunity is part of the project aimed at enhancing the quality and accessibility of oncological diagnostics and treatment at the University Clinical Center (UCK). The project is funded under the National Recovery and Resilience Plan, specifically Component D, which focuses on imp
This contract involves the delivery of pharmaceutical products as specified in the attached document (Annex 3 to the SWZ). The estimated quantity and specific requirements for the products are detailed in that annex. Suppliers are invited to provide these medical products to the University Clinical
This contract involves the supply of lung perfusion products and buffered extracellular fluid for lung perfusion. Suppliers are required to provide the products as specified in Annex 3a and Annex 3b of the procurement documentation. The estimated quantities and specific requirements for these produc
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
